APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
暂无分享,去创建一个
Michel Henry | Peter Sommer | Simon Wain-Hobson | Sylvie Pochet | N. Navaratnam | S. Pochet | S. Wain-Hobson | J. Vartanian | D. Guétard | M. Henry | P. Sommer | Rodolphe Suspène | Stéphane Ferris | Denise Guétard | Ann Chester | Naveenan Navaratnam | Jean-Pierre Vartanian | S. Ferris | R. Suspène | A. Chester
[1] Reuben S Harris,et al. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. , 2004, Journal of molecular biology.
[2] Reuben S Harris,et al. The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G , 2003, Current Biology.
[3] Yunkai Yu,et al. Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.
[4] T. Honjo,et al. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Malim,et al. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif , 2003, Nature Medicine.
[6] M. Marin,et al. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation , 2003, Nature Medicine.
[7] B. Cullen. HIV-1 Vif: counteracting innate antiretroviral defenses. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[8] S. Wain-Hobson,et al. Death and the retrovirus. , 2003, Trends in molecular medicine.
[9] W. Greene,et al. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. , 2003, Molecular cell.
[10] John M. Coffin,et al. Weapons of Mutational Destruction , 2003, Science.
[11] S. Goff. Death by Deamination A Novel Host Restriction System for HIV-1 , 2003, Cell.
[12] R. König,et al. Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.
[13] Wesley I. Sundquist,et al. Good to CU , 2003, Nature.
[14] M. Goodman,et al. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation , 2003, Nature.
[15] Hui Zhang,et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA , 2003, Nature.
[16] Gersende Caron,et al. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.
[17] M. Malim,et al. DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses , 2003, Nature Immunology.
[18] M. Malim,et al. DNA Deamination Mediates Innate Immunity to Retroviral Infection , 2003, Cell.
[19] Reuben S Harris,et al. Immunity through DNA deamination. , 2003, Trends in biochemical sciences.
[20] F. Clavel,et al. Hypermutation of HIV-1 DNA in the Absence of the Vif Protein , 2003, Science.
[21] M. Malim,et al. Comprehensive Investigation of the Molecular Defect in vif-Deficient Human Immunodeficiency Virus Type 1 Virions , 2003, Journal of Virology.
[22] M. Nussenzweig,et al. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand , 2003, Nature Immunology.
[23] F. Alt,et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme , 2003, Nature.
[24] M. Goodman,et al. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] Reuben S Harris,et al. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.
[26] M. Malim,et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.
[27] M. Neuberger,et al. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.
[28] Michel Henry,et al. Sustained G-->A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. , 2002, The Journal of general virology.
[29] I. Dunham,et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. , 2002, Genomics.
[30] N. Navaratnam,et al. Novel Role for RNA-binding Protein CUGBP2 in Mammalian RNA Editing , 2001, The Journal of Biological Chemistry.
[31] F. McCutchan,et al. Human Immunodeficiency Virus Type 1 DNA Sequences Genetically Damaged by Hypermutation Are Often Abundant in Patient Peripheral Blood Mononuclear Cells and May Be Generated during Near-Simultaneous Infection and Activation of CD4+ T Cells , 2001, Journal of Virology.
[32] J. Arnold,et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen , 2000, Nature Medicine.
[33] L. Mansky. In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy , 2000, Journal of Virology.
[34] A. Fischer,et al. Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2) , 2000, Cell.
[35] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[36] L. Pearl,et al. A read-ahead function in archaeal DNA polymerases detects promutagenic template-strand uracil. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Mullins,et al. Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Desrosiers,et al. Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus , 1998, Journal of Virology.
[39] S. Günther,et al. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation. , 1997, Virology.
[40] A. Meyerhans,et al. HIV genetic variation is directed and restricted by DNA precursor availability. , 1997, Journal of molecular biology.
[41] L. M. Mansky,et al. The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene. , 1996, Virology.
[42] Miguel Ángel Martínez,et al. Exploring the functional robustness of an enzyme by in vitro evolution. , 1996, The EMBO journal.
[43] S. Wain-Hobson,et al. Human immunodeficiency virus type 1 reverse transcriptase tG:T mispair formation on RNA and DNA templates with mismatched primers: a kinetic and thermodynamic study. , 1995, The EMBO journal.
[44] L. M. Mansky,et al. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.
[45] A Gazit,et al. Erratic G-->A hypermutation within a complete caprine arthritis-encephalitis virus (CAEV) provirus. , 1995, Virology.
[46] P. Charneau,et al. A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis. , 1995, Virology.
[47] S. Wain-Hobson,et al. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] W. Stemmer. Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.
[49] M Sala,et al. G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Fitzgibbon,et al. A new type of G-->A hypermutation affecting human immunodeficiency virus. , 1993, AIDS research and human retroviruses.
[51] C. Burant,et al. Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.
[52] F. Gao,et al. Human infection by genetically diverse SIVSM-related HIV-2 in West Africa , 1992, Nature.
[53] L. Whetter,et al. The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro , 1992, Journal of virology.
[54] R. Yolken,et al. Use of modified nucleotides and uracil-DNA glycosylase (UNG) for the control of contamination in the PCR-based amplification of RNA. , 1992, Molecular and cellular probes.
[55] A. Meyerhans,et al. Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes , 1991, Journal of virology.
[56] V. Pathak,et al. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[57] Roberto Cattaneo,et al. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections , 1988, Cell.
[58] J. Mullins,et al. The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein , 1987, Cell.
[59] Xianghui Yu,et al. Induction of APOBEC 3 G Ubiquitination and Degradation by an HIV-1 Vif-Cul 5-SCF Complex , 2022 .